ARI-2014.06.30-10Q
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________________________________
FORM 10-Q
__________________________________
(Mark One)
|
| |
x | Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
For the quarterly period ended June 30, 2014
|
| |
¨ | Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
For the transition period from to
Commission File Number: 001-34452
__________________________________
Apollo Commercial Real Estate Finance, Inc.
(Exact name of registrant as specified in its charter)
__________________________________
|
| | |
Maryland | | 27-0467113 |
(State or other jurisdiction of incorporation or organization) | | (I.R.S. Employer Identification Number) |
Apollo Commercial Real Estate Finance, Inc.
c/o Apollo Global Management, LLC
9 West 57th Street, 43rd Floor,
New York, New York 10019
(Address of registrant’s principal executive offices)
(212) 515–3200
(Registrant’s telephone number, including area code)
__________________________________
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act (check one):
|
| | | | | | |
Large accelerated filer | | ¨ | | Accelerated filer | | x |
| | | | | | |
Non-accelerated filer | | ¨ (Do not check if a smaller reporting company) | | Smaller Reporting Company | | ¨ |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practical date.
As of July 30, 2014, there were 46,848,675 shares, par value $0.01, of the registrant’s common stock issued and outstanding.
Table of Contents
Part I — FINANCIAL INFORMATION
ITEM 1. Financial Statements
Apollo Commercial Real Estate Finance, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets (Unaudited)
(in thousands—except share and per share data)
|
| | | | | | | |
| June 30, 2014 | | December 31, 2013 |
Assets: | | | |
Cash | $ | 63,335 |
| | $ | 20,096 |
|
Restricted cash | 30,127 |
| | 30,127 |
|
Securities available-for-sale, at estimated fair value | 23,281 |
| | 33,362 |
|
Securities, at estimated fair value | 324,724 |
| | 158,086 |
|
Commercial mortgage loans, held for investment | 343,810 |
| | 161,099 |
|
Subordinate loans, held for investment | 748,227 |
| | 497,484 |
|
Interest receivable | 15,183 |
| | 6,022 |
|
Deferred financing costs, net | 5,088 |
| | 628 |
|
Other assets | 975 |
| | 600 |
|
Total Assets | $ | 1,554,750 |
| | $ | 907,504 |
|
Liabilities and Stockholders’ Equity | | | |
Liabilities: | | | |
Borrowings under repurchase agreements | $ | 446,224 |
| | $ | 202,033 |
|
Convertible senior notes, net | 139,362 |
| | — |
|
Participations sold | 89,182 |
| | — |
|
Derivative instrument | 1,093 |
| | — |
|
Accounts payable and accrued expenses | 5,260 |
| | 2,660 |
|
Payable to related party | 2,966 |
| | 2,628 |
|
Dividends payable | 20,665 |
| | 17,227 |
|
Total Liabilities | 704,752 |
| | 224,548 |
|
Commitments and Contingencies (see Note 15) |
| |
|
Stockholders’ Equity: | | | |
Preferred stock, $0.01 par value, 50,000,000 shares authorized, 3,450,000 shares issued and outstanding ($86,250 aggregate liquidation preference) | 35 |
| | 35 |
|
Common stock, $0.01 par value, 450,000,000 shares authorized, 46,848,675 and 36,888,467 shares issued and outstanding, respectively | 468 |
| | 369 |
|
Additional paid-in-capital | 860,421 |
| | 697,610 |
|
Retained earnings (accumulated deficit) | (10,132 | ) | | (14,188 | ) |
Accumulated other comprehensive loss | (794 | ) | | (870 | ) |
Total Stockholders’ Equity | 849,998 |
| | 682,956 |
|
Total Liabilities and Stockholders’ Equity | $ | 1,554,750 |
| | $ | 907,504 |
|
See notes to unaudited condensed consolidated financial statements.
3
Apollo Commercial Real Estate Finance, Inc. and Subsidiaries
Condensed Consolidated Statement of Operations (Unaudited)
(in thousands—except share and per share data)
|
| | | | | | | | | | | | | | | |
| Three months ended June 30, | | Six months ended June 30, |
| 2014 | | 2013 | | 2014 | | 2013 |
Net interest income: | | | | | | | |
Interest income from securities | $ | 4,366 |
| | $ | 3,014 |
| | $ | 6,785 |
| | $ | 6,101 |
|
Interest income from commercial mortgage loans | 6,438 |
| | 3,676 |
| | 10,449 |
| | 7,268 |
|
Interest income from subordinate loans | 18,238 |
| | 11,498 |
| | 32,968 |
| | 22,953 |
|
Interest income from repurchase agreements | — |
| | — |
| | — |
| | 2 |
|
Interest expense | (5,258 | ) | | (955 | ) | | (7,015 | ) | | (2,024 | ) |
Net interest income | 23,784 |
| | 17,233 |
| | 43,187 |
| | 34,300 |
|
Operating expenses: | | | | | | | |
General and administrative expenses (includes $362 and $788 of equity based compensation in 2014 and $428 and $1,311 in 2013, respectively) | (1,479 | ) | | (1,437 | ) | | (2,921 | ) | | (3,333 | ) |
Management fees to related party | (2,966 | ) | | (2,600 | ) | | (5,531 | ) | | (4,759 | ) |
Total operating expenses | (4,445 | ) | | (4,037 | ) | | (8,452 | ) | | (8,092 | ) |
Interest income from cash balances | 4 |
| | 16 |
| | 4 |
| | 16 |
|
Unrealized gain (loss) on securities | 4,749 |
| | (1,421 | ) | | 6,934 |
| | (2,500 | ) |
Foreign currency gain | 959 |
| | — |
| | 959 |
| | — |
|
Loss on derivative instruments (includes $1,093 and $1,093 of unrealized losses in 2014 and $57 and $130 of unrealized gains in 2013, respectively) | (1,093 | ) | | (2 | ) | | (1,093 | ) | | (3 | ) |
Net income | 23,958 |
| | 11,789 |
| | 41,539 |
| | 23,721 |
|
Preferred dividends | (1,860 | ) | | (1,860 | ) | | (3,720 | ) | | (3,720 | ) |
Net income available to common stockholders | $ | 22,098 |
| | $ | 9,929 |
| | $ | 37,819 |
| | $ | 20,001 |
|
Basic and diluted net income per share of common stock | $ | 0.51 |
| | $ | 0.27 |
| | $ | 0.94 |
| | $ | 0.59 |
|
Basic weighted average shares of common stock outstanding | 42,888,747 |
| | 36,880,410 |
| | 40,021,722 |
| | 33,511,889 |
|
Diluted weighted average shares of common stock outstanding | 43,099,354 |
| | 37,373,885 |
| | 40,236,109 |
| | 33,946,329 |
|
Dividend declared per share of common stock | $ | 0.40 |
| | $ | 0.40 |
| | $ | 0.80 |
| | $ | 0.80 |
|
See notes to unaudited condensed consolidated financial statements.
4
Apollo Commercial Real Estate Finance, Inc. and Subsidiaries
Condensed Consolidated Statement of Comprehensive Income (Unaudited)
(in thousands)
|
| | | | | | | | | | | | | | | |
| Three months ended June 30, | | Six months ended June 30, |
| 2014 | | 2013 | | 2014 | | 2013 |
Net income available to common stockholders | $ | 22,098 |
| | $ | 9,929 |
| | $ | 37,819 |
| | $ | 20,001 |
|
Change in net unrealized gain (loss) on securities available-for-sale | 93 |
| | (474 | ) | | 76 |
| | (632 | ) |
Comprehensive income | $ | 22,191 |
| | $ | 9,455 |
| | $ | 37,895 |
| | $ | 19,369 |
|
See notes to unaudited condensed consolidated financial statements.
5
Apollo Commercial Real Estate Finance, Inc. and Subsidiaries
Condensed Consolidated Statement of Changes in Stockholders’ Equity (Unaudited)
(in thousands—except share data)
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Preferred Stock | | Common Stock | | Additional Paid In Capital | | Retained Earnings (Accumulated Deficit) | | Accumulated Other Comprehensive Income | | |
| Shares | | Par | | Shares | | Par | | | | | Total |
Balance at January 1, 2014 | 3,450,000 |
| | $ | 35 |
| | 36,888,467 |
| | $ | 369 |
| | $ | 697,610 |
| | $ | (14,188 | ) | | $ | (870 | ) | | $ | 682,956 |
|
Capital decrease related to Equity Incentive Plan | — |
| | — |
| | 240,277 |
| | 2 |
| | (90 | ) | | — |
| | — |
| | (88 | ) |
Issuance of restricted common stock | — |
| | — |
| | 13,931 |
| | * |
| | — |
| | — |
| | — |
| | — |
|
Issuance of common stock | — |
| | — |
| | 9,706,000 |
| | 97 |
| | 158,596 |
| | — |
| | — |
| | 158,693 |
|
Offering costs | — |
| | — |
| | — |
| | — |
| | (312 | ) | | — |
| | — |
| | (312 | ) |
Convertible senior notes | — |
| | — |
| | — |
| | — |
| | 4,617 |
| | — |
| | — |
| | 4,617 |
|
Net income | — |
| | — |
| | — |
| | — |
| | — |
| | 41,539 |
| | — |
| | 41,539 |
|
Change in net unrealized gain on securities available-for-sale | — |
| | — |
| | — |
| | — |
| | — |
| | — |
| | 76 |
| | 76 |
|
Dividends on common stock | — |
| | — |
| | — |
| | — |
| | — |
| | (33,763 | ) | | — |
| | (33,763 | ) |
Dividends on preferred stock | — |
| | — |
| | — |
| | — |
| | — |
| | (3,720 | ) | | — |
| | (3,720 | ) |
Balance at June 30, 2014 | 3,450,000 |
| | $ | 35 |
| | 46,848,675 |
| | $ | 468 |
| | $ | 860,421 |
| | $ | (10,132 | ) | | $ | (794 | ) | | $ | 849,998 |
|
* Rounds to zero.
See notes to unaudited condensed consolidated financial statements.
6
Apollo Commercial Real Estate Finance, Inc. and Subsidiaries
Condensed Consolidated Statement of Cash Flows (Unaudited)
(in thousands)
|
| | | | | | | |
| Six months ended June 30, 2014 | | Six months ended June 30, 2013 |
Cash flows provided by operating activities: | | | |
Net income | $ | 41,539 |
| | $ | 23,721 |
|
Adjustments to reconcile net income to net cash provided by operating activities: | | | |
Premium amortization and (discount accretion), net | (1,285 | ) | | (1,995 | ) |
Amortization of deferred financing costs | 662 |
| | 415 |
|
Equity-based compensation | (88 | ) | | 1,311 |
|
Unrealized (gain) loss on securities | (6,934 | ) | | 2,500 |
|
Foreign currency gain | (959 | ) | | — |
|
Unrealized gain on derivative instruments | 1,093 |
| | (130 | ) |
Changes in operating assets and liabilities: | | | |
Accrued interest receivable, less purchased interest | (10,459 | ) | | (3,474 | ) |
Other assets | 416 |
| | 203 |
|
Accounts payable and accrued expenses | 2,809 |
| | 110 |
|
Payable to related party | 338 |
| | 563 |
|
Net cash provided by operating activities | 27,132 |
| | 23,224 |
|
Cash flows used in investing activities: | | | |
Fees received from commercial mortgage loans | — |
| | 280 |
|
Funding of securities at estimated fair value | (173,969 | ) | | — |
|
Funding of commercial mortgage loans | (181,590 | ) | | — |
|
Funding of subordinate loans | (318,922 | ) | | (174,190 | ) |
Funding of other assets | (1,256 | ) | | — |
|
Principal payments received on securities available-for-sale | 9,969 |
| | 13,267 |
|
Principal payments received on securities at estimated fair value | 14,009 |
| | 25,415 |
|
Principal payments received on commercial mortgage loans | 452 |
| | 813 |
|
Principal payments received on subordinate loans | 71,434 |
| | 68,779 |
|
Principal payments received on other assets | 21 |
| | — |
|
Principal payments received on repurchase agreements | — |
| | 6,598 |
|
Net cash used in investing activities | (579,852 | ) | | (59,038 | ) |
Cash flows from financing activities: | | | |
Proceeds from issuance of common stock | 158,693 |
| | 148,804 |
|
Payment of offering costs | (208 | ) | | (776 | ) |
Proceeds from repurchase agreement borrowings | 297,665 |
| | — |
|
Repayments of repurchase agreement borrowings | (53,475 | ) | | (33,846 | ) |
Proceeds from issuance of convertible senior notes | 143,750 |
| | — |
|
Participations sold | 89,012 |
| | — |
|
Payment of deferred financing costs | (5,433 | ) | | (505 | ) |
Dividends on common stock | (30,325 | ) | | (25,965 | ) |
Dividends on preferred stock | (3,720 | ) | | (3,720 | ) |
Net cash provided by financing activities | 595,959 |
| | 83,992 |
|
Net increase in cash and cash equivalents | 43,239 |
| | 48,178 |
|
Cash and cash equivalents, beginning of period | 20,096 |
| | 108,619 |
|
Cash and cash equivalents, end of period | $ | 63,335 |
| | $ | 156,797 |
|
Supplemental disclosure of cash flow information: | | | |
Interest paid | $ | 2,998 |
| | $ | 916 |
|
Supplemental disclosure of non-cash financing activities: | | | |
Dividend declared, not yet paid | $ | 20,665 |
| | $ | 16,821 |
|
Deferred financing costs, not yet paid | $ | — |
| | $ | 250 |
|
Offering costs payable | $ | 212 |
| | $ | 47 |
|
See notes to unaudited condensed consolidated financial statements.
7
Apollo Commercial Real Estate Finance Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements (Unaudited)
(in thousands—except share and per share data)
Note 1 – Organization
Apollo Commercial Real Estate Finance, Inc. (together with its consolidated subsidiaries, is referred to throughout this report as the “Company,” “ARI,” “we,” “us” and “our”) is a real estate investment trust (“REIT”) that primarily originates, acquires, invests in and manages performing commercial first mortgage loans, subordinate financings, commercial mortgage-backed securities (“CMBS”) and other commercial real estate-related debt investments. These asset classes are referred to as the Company’s target assets.
Note 2 – Summary of Significant Accounting Policies
Basis of Presentation
The accompanying consolidated financial statements include the Company’s accounts and those of its consolidated subsidiaries. All intercompany amounts have been eliminated. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. The Company’s most significant estimates include the fair value of financial instruments and loan loss reserve. Actual results could differ from those estimates.
These unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013, as filed with the Securities and Exchange Commission (the “SEC”). In the opinion of management, all adjustments (consisting only of normal recurring adjustments) necessary to present fairly the Company’s financial position, results of operations and cash flows have been included.
The Company currently operates in one business segment.
Significant Accounting Policies
Foreign Currency. The Company may enter into transactions not denominated in United States, or U.S., dollars. Foreign exchange gains and losses arising on such transactions are recorded as a gain or loss in the Company's consolidated statements of operations. Non-U.S. dollar denominated assets and liabilities are translated to U.S. dollars at the exchange rate prevailing at the reporting date and income, expenses, gains, and losses are translated at the prevailing exchange rate on the dates that they were recorded.
Participations Sold. Participations sold represent interests in certain loans that the Company originated and subsequently sold. In certain instances, the Company presents these participations sold as both assets and non-recourse liabilities because these arrangements do not qualify as sales under GAAP. Generally, participations sold are recorded as assets and liabilities in equal amounts on the Company's consolidated balance sheets, and an equivalent amount of interest income and interest expense is recorded on the Company's consolidated statements of operations.
Recent Accounting Pronouncements
In June 2013, the Financial Accounting Standards Board (the "FASB") issued guidance to change the assessment of whether an entity is an investment company by developing a new two-tiered approach that requires an entity to possess certain fundamental characteristics while allowing judgment in assessing certain typical characteristics. The fundamental characteristics that an investment company is required to have include the following: (1) it obtains funds from one or more investors and provides the investor(s) with investment management services; (2) it commits to its investor(s) that its business purpose and only substantive activities are investing the funds solely for returns from capital appreciation, investment income or both; and (3) it does not obtain returns or benefits from an investee or its affiliates that are not normally attributable to ownership interests. The typical characteristics of an investment company that an entity should consider before concluding whether it is an investment company include the following: (1) it has more than one investment; (2) it has more than one investor; (3) it has investors that are not related parties of the parent or the investment manager; (4) it has ownership interests in the form of equity or partnership interests; and (5) it manages substantially all of its investments on a fair value basis. The new approach requires an entity to assess all of the characteristics of an investment company and consider its purpose and design to determine whether it is an investment company. The guidance includes disclosure requirements about an entity’s status as an investment company and financial support provided or contractually required to be provided by an investment company to its
investees. The guidance is effective for interim and annual reporting periods in fiscal years beginning after December 15, 2013. Earlier application is prohibited. The Accounting Standards Update ("ASU") prohibits REITs from qualifying for investment company accounting under ASC 946, as such, we have determined that we will not meet the definition of an investment company under this ASU.
In June 2014, the FASB issued guidance which amends the accounting guidance for repurchase-to-maturity transactions and repurchase agreements executed as repurchase financings, and requires additional disclosure about certain transactions by the transferor. The guidance is effective for certain transactions that qualify for sales treatment for the first interim or annual period beginning after December 15, 2014. The new disclosure requirements for repurchase agreements, securities lending transactions and repurchase-to-maturity transactions that qualify for secured borrowing treatment is effective for annual periods beginning after December 15, 2014 and for interim periods beginning after March 15, 2014. The Company currently records repurchase arrangements as secured borrowings and does not anticipate this guidance will have an impact on the Company's consolidated financial statements.
In May 2014, the FASB issued guidance which broadly amends the accounting guidance for revenue recognition. This guidance is effective for the first interim or annual period beginning after December 15, 2016, and is to be applied prospectively. The Company does not anticipate that the adoption of this guidance will have a material impact on the Company's consolidated financial statements.
Note 3 – Fair Value Disclosure
GAAP establishes a hierarchy of valuation techniques based on observable inputs utilized in measuring financial instruments at fair values. Market based or observable inputs are the preferred source of values, followed by valuation models using management assumptions in the absence of market inputs. The three levels of the hierarchy are described below:
Level I — Quoted prices in active markets for identical assets or liabilities.
Level II — Prices are determined using other significant observable inputs. Observable inputs are inputs that other market participants would use in pricing a security. These may include quoted prices for similar securities, interest rates, prepayment speeds, credit risk and others.
Level III — Prices are determined using significant unobservable inputs. In situations where quoted prices or observable inputs are unavailable (for example, when there is little or no market activity for an investment at the end of the period), unobservable inputs may be used.
While the Company anticipates that its valuation methods will be appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date. The Company will use inputs that are current as of the measurement date, which may include periods of market dislocation, during which price transparency may be reduced.
The estimated fair value of the CMBS portfolio is determined by reference to market prices provided by certain dealers who make a market in these financial instruments. Broker quotes are only indicative of fair value and may not necessarily represent what the Company would receive in an actual trade for the applicable instrument. Management performs additional analysis on prices received based on broker quotes to validate the prices and adjustments are made as deemed necessary by management to capture current market information. The estimated fair values of the Company’s securities are based on observable market parameters and are classified as Level II in the fair value hierarchy.
The estimated fair values of the Company’s derivative instruments are determined using a discounted cash flow analysis on the expected cash flows of each derivative. The fair values of interest rate swaps are determined using the market standard methodology of netting the discounted future fixed cash receipts (or payments) and the discounted expected variable cash payments (or receipts). The fair values of interest rate caps are determined using the market standard methodology of discounting the future expected cash receipts that would occur if variable interest rates rise above the strike rate of the caps. The variable interest rates used in the calculation of projected cash flows are based on an expectation of future interest rates derived from observable market interest rate curves and volatilities. The Company’s derivative instruments are classified as Level II in the fair value hierarchy.
The following table summarizes the levels in the fair value hierarchy into which the Company’s financial instruments were categorized as of June 30, 2014 and December 31, 2013:
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Fair Value as of June 30, 2014 | | Fair Value as of December 31, 2013 |
| Level I | | Level II | | Level III | | Total | | Level I | | Level II | | Level III | | Total |
CMBS (Available-for-Sale) | $ | — |
| | $ | 23,281 |
| | $ | — |
| | $ | 23,281 |
| | $ | — |
| | $ | 33,362 |
| | $ | — |
| | $ | 33,362 |
|
CMBS (Fair Value Option) | — |
| | 324,724 |
| | — |
| | 324,724 |
| | — |
| | 158,086 |
| | — |
| | 158,086 |
|
Total | $ | — |
| | $ | 348,005 |
| | $ | — |
| | $ | 348,005 |
| | $ | — |
| | $ | 191,448 |
| | $ | — |
| | $ | 191,448 |
|
Note 4 – Debt Securities
At June 30, 2014, all of the Company's CMBS were pledged to secure borrowings under the Company’s master repurchase agreements with Wells Fargo Bank, N.A. (“Wells Fargo”) (the “Wells Facility”), UBS AG, London Branch ("UBS") (the "UBS Facility") and Deutsche Bank AG ("DB") (the "DB Facility"). (See Note 8 for a description of these facilities).
The amortized cost and estimated fair value of the Company’s debt securities at June 30, 2014 are summarized as follows:
|
| | | | | | | | | | | | | | | | | | | |
Security Description | Face Amount | | Amortized Cost | | Gross Unrealized Gain | | Gross Unrealized Loss | | Estimated Fair Value |
CMBS (Available-for-Sale) | $ | 23,097 |
| | $ | 24,074 |
| | $ | — |
| | $ | (793 | ) | | $ | 23,281 |
|
CMBS (Fair Value Option) | 320,499 |
| | 315,650 |
| | 9,143 |
| | (69 | ) | | 324,724 |
|
Total | $ | 343,596 |
| | $ | 339,724 |
| | $ | 9,143 |
| | $ | (862 | ) | | $ | 348,005 |
|
The gross unrealized loss related to the available-for-sale securities results from the fair value of the securities falling below the amortized cost basis. The unrealized losses are primarily the result of market factors other than credit impairment and the Company believes the carrying value of the securities are fully recoverable over their expected holding period. Management does not intend to sell or expect to be forced to sell the securities prior to the Company recovering the amortized cost. As such, management does not believe any of the securities are other than temporarily impaired.
The amortized cost and estimated fair value of the Company’s debt securities at December 31, 2013 are summarized as follows:
|
| | | | | | | | | | | | | | | | | | | |
Security Description | Face Amount | | Amortized Cost | | Gross Unrealized Gain | | Gross Unrealized Loss | | Estimated Fair Value |
CMBS (Available-for-Sale) | $ | 33,066 |
| | $ | 34,232 |
| | $ | — |
| | $ | (870 | ) | | $ | 33,362 |
|
CMBS (Fair Value Option) | 155,577 |
| | 155,946 |
| | 2,313 |
| | (173 | ) | | 158,086 |
|
Total | $ | 188,643 |
| | $ | 190,178 |
| | $ | 2,313 |
| | $ | (1,043 | ) | | $ | 191,448 |
|
The overall statistics for the Company’s CMBS investments calculated on a weighted average basis assuming no early prepayments or defaults as of June 30, 2014 and December 31, 2013 are as follows:
|
| | | | | |
| June 30, 2014 | | December 31, 2013 |
Credit Ratings * | AAA - CC |
| | AAA - CCC |
|
Coupon | 5.8 | % | | 5.8 | % |
Yield | 6.3 | % | | 5.3 | % |
Weighted Average Life | 2.8 years |
| | 3.1 years |
|
| |
* | Ratings per Fitch Ratings, Moody’s Investors Service or Standard & Poor's. |
The percentage vintage, property type and location of the collateral securing the Company’s CMBS investments calculated on a weighted average basis as of June 30, 2014 and December 31, 2013 are as follows:
|
| | | | | |
Vintage | June 30, 2014 | | December 31, 2013 |
2005 | 13 | % | | — | % |
2006 | 15 |
| | 3 |
|
2007 | 71 |
| | 97 |
|
2008 | 1 |
| | — |
|
Total | 100 | % | | 100 | % |
|
| | | | | |
Property Type | June 30, 2014 | | December 31, 2013 |
Office | 36.6 | % | | 35.5 | % |
Retail | 24.3 |
| | 24.1 |
|
Hotel | 14.2 |
| | 13.7 |
|
Multifamily | 11.4 |
| | 12.7 |
|
Other * | 13.5 |
| | 14.0 |
|
Total | 100 | % | | 100 | % |
* No other individual category comprises more than 10% of the total.
|
| | | | | |
Location | June 30, 2014 | | December 31, 2013 |
South Atlantic | 24.0 | % | | 23.4 | % |
Middle Atlantic | 20.3 |
| | 22.8 |
|
Pacific | 17.7 |
| | 17.6 |
|
East North Central | 11.0 |
| | — |
|
Other * | 27.0 |
| | 36.2 |
|
Total | 100 | % | | 100 | % |
* No other individual category comprises more than 10% of the total.
Note 5 – Commercial Mortgage Loans
The Company’s commercial mortgage loan portfolio was comprised of the following at June 30, 2014:
|
| | | | | | | | | | | | | | | | | | | | |
Description | Date of Investment | | Maturity Date | | Original Face Amount | | Current Face Amount | | Carrying Value | | Coupon | | Property Size |
Hotel - NY, NY | Jan-10 | | Feb-15 | | $ | 32,000 |
| | $ | 31,179 |
| | $ | 31,179 |
| | Fixed |
| | 151 rooms |
Office Condo (Headquarters) - NY, NY | Feb-10 | | Feb-15 | | 28,000 |
| | 27,032 |
| | 27,032 |
| | Fixed |
| | 73,419 sq. ft. |
Hotel - Silver Spring, MD | Mar-10 | | Apr-15 | | 26,000 |
| | 24,770 |
| | 24,670 |
| | Fixed |
| | 263 rooms |
Condo Conversion – NY, NY (1) | Dec-12 | | Jan-15 | | 45,000 |
| | 45,000 |
| | 45,142 |
| | Floating |
| | 119,000 sq. ft. |
Condo Conversion – NY, NY (2) | Aug-13 | | Sept-15 | | 33,000 |
| | 33,504 |
| | 33,442 |
| | Floating |
| | 40,000 sq. ft. |
Condo Construction - Potomac, MD (3) | Feb-14 | | Sept-16 | | 25,000 |
| | 25,000 |
| | 24,320 |
| | Floating |
| | 50 units |
Vacation Home Portfolio - Various | Apr-14 | | Apr-19 | | 106,000 |
| | 106,000 |
| | 104,953 |
| | Fixed |
| | 229 properties |
Hotel - Philadelphia, PA (1) | May-14 | | May-17 | | 34,000 |
| | 34,000 |
| | 33,698 |
| | Floating |
| | 301 rooms |
Condo Construction - Bethesda, MD (4) | Jun-14 | | Dec-16 | | 20,000 |
| | 20,000 |
| | 19,374 |
| | Floating |
| | 40 units |
Total/Weighted Average | | | | | $ | 349,000 |
| | $ | 346,485 |
| | $ | 343,810 |
| | 8.64 | % | | |
| |
(1) | This loan includes two one-year extension options subject to certain conditions and the payment of a fee for each extension. |
| |
(2) | This loan includes a one-year extension option subject to certain conditions and the payment of a fee. |
| |
(3) | This loan includes a six-month extension option subject to certain conditions and the payment of a fee. As of June 30, 2014, the Company had $55,000 of unfunded loan commitments related to this loan. |
| |
(4) | This loan includes a six-month extension option subject to certain conditions and the payment of a fee. As of June 30, 2014, the Company had $45,100 of unfunded loan commitments related to this loan. |
The Company’s commercial mortgage loan portfolio was comprised of the following at December 31, 2013:
|
| | | | | | | | | | | | | | | | | | | | |
Description | Date of Investment | | Maturity Date | | Original Face Amount | | Current Face Amount | | Carrying Value | | Coupon | | Property Size |
Hotel - NY, NY | Jan-10 | | Feb-15 | | $ | 32,000 |
| | $ | 31,317 |
| | $ | 31,317 |
| | Fixed |
| | 151 rooms |
Office Condo (Headquarters) - NY, NY | Feb-10 | | Feb-15 | | 28,000 |
| | 27,169 |
| | 27,169 |
| | Fixed |
| | 73,419 sq. ft. |
Hotel - Silver Spring, MD | Mar-10 | | Apr-15 | | 26,000 |
| | 24,947 |
| | 24,785 |
| | Fixed |
| | 263 rooms |
Condo Conversion – NY, NY (1) | Dec-12 | | Jan-15 | | 45,000 |
| | 45,000 |
| | 44,867 |
| | Floating |
| | 119,000 sq. ft. |
Condo Conversion – NY, NY (2) | Aug-13 | | Sept-15 | | 33,000 |
| | 33,167 |
| | 32,961 |
| | Floating |
| | 40,000 sq. ft. |
Total/Weighted Average | | | | | $ | 164,000 |
| | $ | 161,600 |
| | $ | 161,099 |
| | 8.82 | % | | |
| |
(1) | This loan includes two one-year extension options subject to certain conditions and the payment of a fee for each extension. |
| |
(2) | This loan includes a one-year extension option subject to certain conditions and the payment of a fee. |
The Company evaluates its loans for possible impairment on a quarterly basis. The Company regularly evaluates the extent and impact of any credit deterioration associated with the performance and/or value of the underlying collateral property as well as the financial and operating capability of the borrower/sponsor on a loan by loan basis. Specifically, a property’s operating results and any cash reserves are analyzed and used to assess (i) whether cash from operations are sufficient to cover the debt service requirements currently and into the future, (ii) the ability of the borrower to refinance the loan and/or (iii) the property’s liquidation value. The Company also evaluates the financial wherewithal of any loan guarantors as well as the borrower’s competency in managing and operating the properties. In addition, the Company considers the overall economic environment, real estate sector and geographic sub-market in which the borrower operates. Such loan loss analyses are completed and reviewed by asset management and finance personnel who utilize various data sources, including (i) periodic financial data such as debt service coverage ratio, property occupancy, tenant profile, rental rates, operating expenses, the borrower’s exit plan, and capitalization and discount rates, (ii) site inspections and (iii) current credit spreads and discussions with market participants. An allowance for loan loss is established when it is deemed probable that the Company will not be able to collect all amounts due according to the contractual terms of the loan. The Company has determined that an allowance for loan losses was not necessary at June 30, 2014 and December 31, 2013.
Note 6 – Subordinate Loans
The Company’s subordinate loan portfolio was comprised of the following at June 30, 2014:
|
| | | | | | | | | | | | | | | | | | |
Description | Date of Investment | | Maturity Date | | Original Face Amount | | Current Face Amount | | Carrying Value | | Coupon |
Office - Michigan | May-10 | | Jun-20 | | $ | 9,000 |
| | $ | 8,839 |
| | $ | 8,839 |
| | Fixed |
|
Ski Resort - California | Apr-11 | | May-17 | | 40,000 |
| | 40,000 |
| | 39,660 |
| | Fixed |
|
Mixed Use – North Carolina | Jul-12 | | Jul-22 | | 6,525 |
| | 6,525 |
| | 6,525 |
| | Fixed |
|
Office Complex - Missouri | Sept-12 | | Oct-22 | | 10,000 |
| | 9,781 |
| | 9,781 |
| | Fixed |
|
Hotel Portfolio – Various (1) | Nov-12 | | Nov-15 | | 50,000 |
| | 47,717 |
| | 47,767 |
| | Floating |
|
Condo Conversion – NY, NY (2) | Dec-12 | | Jan-15 | | 35,000 |
| | 35,000 |
| | 35,026 |
| | Floating |
|
Condo Construction – NY, NY (1) | Jan-13 | | Jul-17 | | 60,000 |
| | 71,399 |
| | 70,969 |
| | Fixed |
|
Multifamily Conversion – NY, NY (1) | Jan-13 | | Dec-14 | | 18,000 |
| | 14,608 |
| | 14,592 |
| | Floating |
|
Hotel Portfolio – Rochester, MN | Jan-13 | | Feb-18 | | 25,000 |
| | 24,628 |
| | 24,628 |
| | Fixed |
|
Warehouse Portfolio - Various | May-13 | | May-23 | | 32,000 |
| | 32,000 |
| | 32,000 |
| | Fixed |
|
Multifamily Conversion – NY, NY (3) | May-13 | | Sept-14 | | 44,000 |
| | 44,000 |
| | 43,917 |
| | Floating |
|
Office Condo - NY, NY | Jul-13 | | Jul-22 | | 14,000 |
| | 14,000 |
| | 13,579 |
| | Fixed |
|
Condo Conversion – NY, NY (4) | Aug-13 | | Sept-15 | | 29,400 |
| | 29,451 |
| | 29,240 |
| | Floating |
|
Mixed Use - Pittsburgh, PA (1) | Aug-13 | | Aug-16 | | 22,500 |
| | 22,500 |
| | 22,411 |
| | Floating |
|
Mixed Use - Florida (2) | Nov-13 | | Oct-18 | | 50,000 |
| | 44,910 |
| | 44,581 |
| | Floating |
|
Mixed Use - Various (2) | Dec-13 | | Dec-18 | | 17,000 |
| | 18,134 |
| | 17,945 |
| | Fixed |
|
Mixed Use - London, England | Apr-14 | | Jan-15 | | 54,926 |
| | 54,926 |
| | 54,926 |
| | Fixed |
|
Hotel - Aruba (2) | May-14 | | May-17 | | 155,000 |
| | 155,000 |
| | 153,591 |
| | Floating |
|
Hotel - NY, NY | Jun-14 | | Dec-14 | | 28,250 |
| | 28,250 |
| | 28,250 |
| | Fixed |
|
Healthcare Portfolio - Various (5) | Jun-14 | | Jun-16 | | 50,000 |
| | 50,000 |
| | 50,000 |
| | Floating |
|
Total/Weighted Average | | | | | $ | 750,601 |
| | $ | 751,668 |
| | $ | 748,227 |
| | 10.30 | % |
| |
(1) | Includes a one-year extension option subject to certain conditions and the payment of an extension fee. |
| |
(2) | Includes two one-year extension options subject to certain conditions and the payment of a fee for each extension. |
| |
(3) | Includes a three-month extension option subject to certain conditions and the payment of an extension fee. |
| |
(4) | Includes a one-year extension option subject to certain conditions and the payment of an extension fee. |
| |
(5) | Includes three one-year extensions options subject to certain conditions and the payment of a fee for each extension. |
During January 2014, the Company received a $15,000 principal repayment from a subordinate loan secured by a pledge of the equity interests in the owner of a New York City hotel. The Company realized a 14% internal rate of return ("IRR") on this subordinate loan. See below for a description of how the IRR is calculated.
During June 2014, the Company received a $47,000 principal repayment from a mezzanine loan secured by a pledge of the equity interests in a portfolio of skilled nursing facilities. The Company realized a 12% IRR on this mezzanine loan.
IRR is the annualized effective compounded return rate that accounts for the time-value of money and represents the rate of return on an investment over a holding period expressed as a percentage of the investment. It is the discount rate that makes the net present value of all cash outflows (the costs of investment) equal to the net present value of cash inflows (returns on investment). It is derived from the negative and positive cash flows resulting from or produced by each transaction (or for a transaction involving more than one investment, cash flows resulting from or produced by each of the investments), whether positive, such as investment returns, or negative, such as transaction expenses or other costs of investment, taking into account the dates on which such cash flows occurred or are expected to occur, and compounding interest accordingly.
The Company’s subordinate loan portfolio was comprised of the following at December 31, 2013:
|
| | | | | | | | | | | | | | | | | | |
Description | Date of Investment | | Maturity Date | | Original Face Amount | | Current Face Amount | | Carrying Value | | Coupon |
Office - Michigan | May-10 | | Jun-20 | | $ | 9,000 |
| | $ | 8,866 |
| | $ | 8,866 |
| | Fixed |
|
Ski Resort - California | Apr-11 | | May-17 | | 40,000 |
| | 40,000 |
| | 39,781 |
| | Fixed |
|
Hotel– New York (1) | Jan-12 | | Feb-14 | | 15,000 |
| | 15,000 |
| | 15,207 |
| | Fixed |
|
Mixed Use – North Carolina | Jul-12 | | Jul-22 | | 6,525 |
| | 6,525 |
| | 6,525 |
| | Fixed |
|
Office Complex - Missouri | Sept-12 | | Oct-22 | | 10,000 |
| | 9,849 |
| | 9,849 |
| | Fixed |
|
Hotel Portfolio – Various (1) | Nov-12 | | Nov-15 | | 50,000 |
| | 48,431 |
| | 48,397 |
| | Floating |
|
Condo Conversion – NY, NY (2) | Dec-12 | | Jan-15 | | 35,000 |
| | 35,000 |
| | 34,734 |
| | Floating |
|
Condo Construction – NY, NY (1) | Jan-13 | | Jul-17 | | 60,000 |
| | 66,800 |
| | 66,340 |
| | Fixed |
|
Multifamily Conversion – NY, NY (1) | Jan-13 | | Dec-14 | | 18,000 |
| | 18,000 |
| | 17,906 |
| | Floating |
|
Hotel Portfolio – Rochester, MN | Jan-13 | | Feb-18 | | 25,000 |
| | 24,771 |
| | 24,771 |
| | Fixed |
|
Warehouse Portfolio - Various | May-13 | | May-23 | | 32,000 |
| | 32,000 |
| | 32,000 |
| | Fixed |
|
Multifamily Conversion – NY, NY (3) | May-13 | | Jun-14 | | 44,000 |
| | 44,000 |
| | 43,859 |
| | Floating |
|
Office Condo - NY, NY | Jul-13 | | Jul-22 | | 14,000 |
| | 14,000 |
| | 13,565 |
| | Fixed |
|
Condo Conversion – NY, NY (4) | Aug-13 | | Sept-15 | | 294 |
| | 295 |
| | 2 |
| | Floating |
|
Mixed Use - Pittsburgh, PA (1) | Aug-13 | | Aug-16 | | 22,500 |
| | 22,500 |
| | 22,342 |
| | Floating |
|
Healthcare Portfolio - Various | Oct-13 | | Jun-14 | | 47,000 |
| | 47,000 |
| | 47,000 |
| | Floating |
|
Mixed Use - Florida (2) | Nov-13 | | Oct-18 | | 50,000 |
| | 50,000 |
| | 49,535 |
| | Floating |
|
Mixed Use - Various (2) | Dec-13 | | Dec-18 | | 17,000 |
| | 17,000 |
| | 16,805 |
| | Fixed |
|
Total/Weighted Average | | | | | $ | 495,319 |
| | $ | 500,037 |
| | $ | 497,484 |
| | 11.60 | % |
| |
(1) | Includes a one-year extension option subject to certain conditions and the payment of an extension fee. |
| |
(2) | Includes two one-year extension options subject to certain conditions and the payment of a fee for each extension. |
| |
(3) | Includes a three-month extension option subject to certain conditions and the payment of an extension fee. |
| |
(4) | Includes a one-year extension option subject to certain conditions and the payment of an extension fee. As of December 31, 2013, the Company had $29,106 of unfunded loan commitments related to this loan. |
During February 2013, the Company received principal repayment on two mezzanine loans totaling $50,000 secured by a portfolio of retail shopping centers located throughout the United States. In connection with the repayment, the Company received a yield maintenance payment totaling $2,500. With the yield maintenance payment, the Company realized a 15% IRR on its mezzanine loan investment.
During June 2013, the Company received the repayment of a $15,000 mezzanine loan secured by a hotel in New York City. In connection with the repayment, the Company received a yield maintenance payment totaling $1,233. With the yield maintenance payment, the Company realized a 19% IRR on its mezzanine loan investment.
The Company evaluates its loans for possible impairment on a quarterly basis. See “Note 5 – Commercial Mortgage Loans” for a summary of the metrics reviewed. The Company has determined that an allowance for loan loss was not necessary at June 30, 2014 and December 31, 2013.
Note 7 – Repurchase Agreement
During 2011, the Company funded a $47,439 investment structured in the form of a repurchase facility secured by a Class A-2 collateralized debt obligation (“CDO”) bond. The $47,439 of borrowings provided under the facility financed the purchase of a CDO bond with an aggregate face amount of $68,726, representing an advance rate of 69% on the CDO bond’s face amount. The CDO was comprised of 58 senior and subordinate commercial real estate debt positions and commercial real estate securities with the majority of the debt and securities underlying the CDO being first mortgages.
The repurchase facility had an interest rate of 13.0% (10.0% current pay with a 3.0% accrual) on amounts outstanding and had an initial term of 18 months with three six-month extensions options available to the borrower. Any principal repayments that occurred prior to the 21st month were subject to a make-whole provision at the full 13.0% interest rate.
In January 2013, the repurchase agreement was repaid in full. Upon the repayment, the Company realized a 17% IRR on its investment.
Note 8 – Borrowings Under Repurchase Agreements
At June 30, 2014 and December 31, 2013, the Company had borrowings outstanding under the Company’s master repurchase agreement with JPMorgan Chase Bank, N.A. (“JPMorgan”) (the “JPMorgan Facility”), the Wells Facility, the UBS Facility and the DB Facility.
At June 30, 2014 and December 31, 2013, the Company’s borrowings had the following debt balances, weighted average maturities and interest rates:
|
| | | | | | | | | | | | | | | | | | | |
| June 30, 2014 | | December 31, 2013 | | |
| Debt Balance | | Weighted Average Remaining Maturity | | Weighted Average Rate | | Debt Balance | | Weighted Average Remaining Maturity | | Weighted Average Rate | | |
Wells Facility borrowings | $ | 26,774 |
| | 0.7 years | | 1.0 | % | | $ | 47,751 |
| | 0.2 years | * | 1.2 | % | | ** |
UBS Facility borrowings | 133,899 |
| | 4.2 years | * | 2.8 | % | | 133,899 |
| | 4.7 years | | 2.8 | % | | Fixed |
DB Facility borrowings | 138,853 |
| | 3.8 years | | 3.8 | % | | — |
| | 0.0 years | | — | % | | *** |
JPMorgan Facility borrowings | 146,698 |
| | 0.6 years | | 2.7 | % | | 20,383 |
| | 1.1 years | | 2.7 | % | | L+250 |
Total borrowings | $ | 446,224 |
| | 2.7 years | | 2.9 | % | | $ | 202,033 |
| | 3.3 years | | 2.4 | % | | |
*Assumes extension options are exercised.
**At December 31, 2013, borrowings outstanding under the Wells Facility bore interest at LIBOR plus 105 basis points. At June 30, 2014, borrowings outstanding under the Wells Facility bore interest at LIBOR plus 80 basis points.
*** Advances under the DB Facility accrue interest at a per annum pricing rate based on the rate implied by the fixed rate bid under a fixed for floating interest rate swap for the receipt of payments indexed to three-month U.S. dollar LIBOR, plus a financing spread ranging from 1.80% to 2.32% based on the rating of the collateral pledged.
At June 30, 2014, the Company’s borrowings had the following remaining maturities:
|
| | | | | | | | | | | | | | | | | | | |
| Less than 1 year | | 1 to 3 years | | 3 to 5 years | | More than 5 years | | Total |
Wells Facility borrowings | $ | 26,774 |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | 26,774 |
|
UBS Facility borrowings * | — |
| | 55,046 |
| | 78,853 |
| | — |
| | 133,899 |
|
DB Facility borrowings | — |
| | 90,790 |
| | 48,063 |
| | — |
| | 138,853 |
|
JPMorgan Facility borrowings | 146,698 |
| | — |
| | — |
| | — |
| | 146,698 |
|
Total | $ | 173,472 |
| | $ | 145,836 |
| | $ | 126,916 |
| | $ | — |
| | $ | 446,224 |
|
*Assumes extension option is exercised.
At June 30, 2014, the Company’s collateralized financings were comprised of borrowings outstanding under the Wells Facility, the UBS Facility, the DB Facility and the JPMorgan Facility. The table below summarizes the outstanding balances at June 30, 2014, as well as the maximum and average balances for the six months ended June 30, 2014.
|
| | | | | | | | | | | |
| | | For the six months ended June 30, 2014 |
| Balance at June 30, 2014 | | Maximum Month-End Balance | | Average Month-End Balance |
Wells Facility borrowings | $ | 26,774 |
| | $ | 47,751 |
| | $ | 34,322 |
|
UBS Facility borrowings | 133,899 |
| | 133,899 |
| | 133,899 |
|
DB Facility borrowings | 138,853 |
| | 138,853 |
| | 50,512 |
|
JPMorgan Facility borrowings | 146,698 |
| | 146,741 |
| | 65,635 |
|
Total | $ | 446,224 |
| | | | |
DB Facility. During April 2014, the Company through an indirect wholly-owned subsidiary entered into the DB Facility with DB pursuant to which the Company may borrow up to $100,000 in order to finance the acquisition of CMBS. The DB Facility was amended in May 2014 to permit the Company to borrow up to $200,000, which maximum may be increased one further time at the Company's request by $100,000. The DB Facility has a term of four years, subject to certain restrictions. Advances under the DB Facility accrue interest at a per annum pricing rate based on the rate implied by the fixed rate bid under a fixed for floating interest rate swap for the receipt of payments indexed to three-month U.S. dollar LIBOR, plus a financing spread ranging from 1.80% to 2.32% based on the rating of the collateral pledged. The Company borrows an amount equal to the product of the estimated fair value of the collateral pledged divided by a margin ratio ranging from 125.00% to 181.82% depending on the collateral pledged.
Additionally, beginning on August 1, 2014 and depending on the utilization rate of the facility, a portion of the undrawn amount may be subject to non-use fees. The DB Facility contains customary terms and conditions for repurchase facilities of this type and financial covenants to be met by the Company, including minimum shareholder's equity of 50% of the gross capital proceeds of its initial public offering and any subsequent public or private offerings.
JPMorgan Facility. On April 25, 2014, the Company, through two subsidiaries (the "Funding Subsidiaries"), entered into a letter agreement to temporarily waive, for a period of up to 30 days, compliance with the minimum liquidity covenant under the JPMorgan Facility that requires the Company to maintain minimum liquidity of the greater of 10% of total consolidated recourse indebtedness and $12,500.
On May 9, 2014, the Company and the Funding Subsidiaries entered into an amendment letter to temporarily increase the maximum permitted borrowing under the JPMorgan Facility from $100,000 to approximately $146,814 and amends the terms of the JPMorgan Facility in order to finance the acquisition of certain mezzanine real estate loans. This letter expired on May 23, 2014.
On May 22, 2014, the Company and the Funding Subsidiaries entered into an amendment letter to extend, until June 6, 2014, (i) the temporary increase of the maximum permitted borrowing under the JPMorgan Facility from $100,000 to approximately $146,814 and (ii) the waiver of compliance with the minimum liquidity covenant under the JPMorgan Facility that was previously granted on April 25, 2014.
On June 6, 2014, the Company and the Funding Subsidiaries entered into amendment letters to extend, as applicable, (i) until June 12, 2014, the temporary increase of the maximum permitted borrowing under the JPMorgan Facility from $100,000 to approximately $146,814, and (ii) until July 1, 2014, the waiver of compliance with the minimum liquidity covenant under the JPMorgan Facility that was previously granted on April 25, 2014.
On June 12, 2014, the Company and the Funding Subsidiaries entered into a third amendment and restatement of the JP Morgan Facility (the “Third Amendment and Restatement”) with JPMorgan. The Third Amendment and Restatement amended the JPMorgan Facility to facilitate the financing of mezzanine loans under the JPMorgan Facility and increased the maximum permitted borrowing to $175,000. In connection with the Third Amendment and Restatement, the guarantee provided by the Company for the obligations of the Funding Subsidiaries was also amended to require the Company to hold minimum liquidity equal to the greater of 5% of its total recourse indebtedness and $15,000. The Third Amendment and Restatement contains affirmative and negative covenants and provisions regarding events of default that are customary for similar repurchase facilities. The Third Amendment and Restatement expires in January 2015.
Wells Facility. In February 2014, the maturity date of the Wells Facility was extended to March 2015. In addition, the Company reduced the interest rate to LIBOR plus 80 basis points from LIBOR plus 105 basis points.
The Company was in compliance with the financial covenants under its repurchase agreements at June 30, 2014 and December 31, 2013.
Note 9 – Convertible Senior Notes
On March 17, 2014, the Company issued $143,750 aggregate principal amount of 5.50% Convertible Senior Notes due 2019 (the "2019 Notes"), for which the Company received net proceeds, after deducting the underwriting discount and estimated offering expense payable by the Company of approximately $139,037. At June 30, 2014, the 2019 Notes have a carrying value of $139,362 and an unamortized discount of $4,388. The following table summarizes the terms of the 2019 Notes.
|
| | | | | | | | | | | |
| Principal Amount | Coupon Rate | Effective Rate (1) | Conversion Rate (2) | Maturity Date | Remaining Period of Amortization |
2019 Notes | $ | 143,750 |
| 5.50 | % | 6.25 | % | 55.3649 |
| 3/15/2019 | 4.76 years |
| |
(1) | Effective rate includes the effect of the adjustment for the conversion option, the value of which reduced the initial liability and was recorded in additional paid-in-capital. |
| |
(2) | The Company has the option to settle any conversions in cash, shares of common stock or a combination thereof. The conversion rate represents the number of shares of common stock issuable per $1,000 principal amount of 2019 Notes converted. The if-converted value of the 2019 Notes does not exceed their principal amount at June 30, 2014 since the closing market price of the Company’s common stock of $16.63 per share does not exceed the implicit conversion prices of $18.06 for the 2019 Notes. |
GAAP requires the liability and equity components of convertible debt instruments that may be settled in cash upon conversion (including partial cash settlement) to be separately accounted for in a manner that reflects the issuer’s nonconvertible debt borrowing rate. ASC 470-20 requires that the initial proceeds from the sale of the 2019 Notes be allocated between a liability component and an equity component in a manner that reflects interest expense at the interest rate of similar nonconvertible debt that could have been issued by the Company at such time. The Company measured the fair value of the debt components of the 2019 Notes as of their issuance date based on effective interest rates of 6.25%. As a result, the Company attributed approximately $4,617 of the proceeds to the equity component of the 2019 Notes, which represents the excess proceeds received over the fair value of the liability component of the 2019 Notes at the date of issuance. The equity component of the 2019 Notes have been reflected within additional paid-in capital in the condensed consolidated balance sheet and has a value of $4,388 as of June 30, 2014. The resulting debt discount is being amortized over the period during which the 2019 Notes are expected to be outstanding (the maturity date) as additional non-cash interest expense. The additional non-cash interest expense attributable to each of the 2019 Notes will increase in subsequent reporting periods through the maturity date as the 2019 Notes accrete to their par value over the same period. The aggregate contractual interest expense was approximately $1,977 and $2,284 for the three and six months ended June 30, 2014, respectively. With respect to the amortization of the discount on the liability component of the 2019 Notes as well as the amortization of deferred financing costs, the Company reported additional non-cash interest expense of approximately $199 and $230 for the three and six months ended June 30, 2014.
As of June 30, 2014 potential shares of common stock contingently issuable upon the conversion of the 2019 Notes were excluded from the calculation of diluted income per share because it is management's intent and ability to settle the obligation in cash.
Note 10 – Participations Sold
During May 2014, the Company closed a $155,000 floating-rate whole loan secured by the first mortgage and equity interests in an entity that owns a resort hotel in Aruba. During June 2014, the Company syndicated a $90,000 senior participation in the loan and retained a $65,000 junior participation in the loan.
Participations sold represent the interest in the Aruba loan the Company originated and subsequently sold. The Company presents the participation sold as both assets and non-recourse liabilities because the participation does not qualify as a sale according to GAAP. At June 30, 2014, the Company had one such participation sold with a face amount of $90,000 and a carrying amount of $89,182. The participation sold has a cash coupon of LIBOR plus 440 basis points. The income earned on the participation sold is recorded as interest income and an identical amount is recorded as interest expense on the Company's consolidated statements of operations.
Note 11 – Derivative Instruments
The Company used interest rate swaps and caps to manage exposure to variable cash flows on portions of its borrowings under repurchase agreements. Interest rate swap and cap agreements allow the Company to receive a variable rate cash flow based on LIBOR and pay a fixed rate cash flow, mitigating the impact of this exposure. All of the Company's interest rate swaps and caps matured during the third quarter of 2013.
During April 2014, the Company entered into a forward contract whereby it agreed to sell £34,389 in exchange for $57,631 in January 2015. The forward contract was executed to economically fix the U.S. dollar amounts of foreign denominated cash flows expected to be received related to a foreign denominated loan investment which closed in the second quarter of 2014.
The Company has not designated any of its derivative instruments as hedges under GAAP and therefore, changes in the fair value of the Company's derivatives are recorded directly in earnings. The following table summarizes the amounts
recognized on the consolidated statements of operations related to the Company’s derivatives for the three and six months ended June 30, 2014 and 2013.
|
| | | | | | | | | | | | | | | | |
| | Three months ended June 30, | | Six months ended June 30, |
| Location of Loss Recognized in Income | 2014 | | 2013 | | 2014 | | 2013 |
Interest rate swaps | Loss on derivative instruments – realized * | $ | — |
| | $ | (59 | ) | | $ | — |
| | $ | (133 | ) |
Interest rate swaps | Gain on derivative instruments – unrealized | — |
| | 58 |
| | — |
| | 131 |
|
Forward currency contract | Loss on derivative instruments - unrealized | (1,093 | ) | | — |
| | (1,093 | ) | | — |
|
Interest rate caps | Loss on derivative instruments - unrealized | — |
| | (1 | ) | | — |
| | (1 | ) |
Total | | $ | (1,093 | ) | | $ | (2 | ) | | $ | (1,093 | ) | | $ | (3 | ) |
| |
* | Realized losses represent net amounts accrued for the Company’s derivative instruments during the period. |
Note 12 – Related Party Transactions
Management Agreement
In connection with the Company’s initial public offering in September 2009, the Company entered into a management agreement (the “Management Agreement”) with ACREFI Management, LLC (the “Manager”), which describes the services to be provided by the Manager and its compensation for those services. The Manager is responsible for managing the Company’s day-to-day operations, subject to the direction and oversight of the Company’s board of directors.
Pursuant to the terms of the Management Agreement, the Manager is paid a base management fee equal to 1.5% per annum of the Company’s stockholders’ equity (as defined in the Management Agreement), calculated and payable (in cash) quarterly in arrears.
The current term of the Management Agreement expires on September 29, 2014 and shall be automatically renewed for successive one-year terms on each anniversary thereafter. The Management Agreement may be terminated upon expiration of the one-year extension term only upon the affirmative vote of at least two-thirds of the Company’s independent directors, based upon (1) unsatisfactory performance by the Manager that is materially detrimental to the Company or (2) a determination that the management fee payable to the Manager is not fair, subject to the Manager’s right to prevent such a termination based on unfair fees by accepting a mutually acceptable reduction of management fees agreed to by at least two-thirds of the Company’s independent directors. The Manager must be provided with written notice of any such termination at least 180 days prior to the expiration of the then existing term and will be paid a termination fee equal to three times the sum of the average annual base management fee during the 24-month period immediately preceding the date of termination, calculated as of the end of the most recently completed fiscal quarter prior to the date of termination. Following a meeting by the Company’s independent directors in February 2014, which included a discussion of the Manager’s performance and the level of the management fees thereunder, the Company determined not to seek termination of the Management Agreement.
For the three and six months ended June 30, 2014, respectively, the Company incurred approximately $2,966 and $5,531 in base management fees. For the three and six months ended June 30, 2013, respectively, the Company incurred approximately $2,600 and $4,759 in base management fees. In addition to the base management fee, the Company is also responsible for reimbursing the Manager for certain expenses paid by the Manager on behalf of the Company or for certain services provided by the Manager to the Company. For the three and six months ended June 30, 2014, respectively, the Company recorded expenses totaling $185 and $292 related to reimbursements for certain expenses paid by the Manager on behalf of the Company. For the three and six months ended June 30, 2013, respectively, the Company recorded expenses totaling $108 and $334 related to reimbursements for certain expenses paid by the Manager on behalf of the Company. Expenses incurred by the Manager and reimbursed by the Company are reflected in the respective consolidated statement of operations expense category or the consolidated balance sheet based on the nature of the item.
Included in payable to related party on the consolidated balance sheet at June 30, 2014 and December 31, 2013, respectively is approximately $2,966 and $2,628 for base management fees incurred but not yet paid.
Note 13 – Share-Based Payments
On September 23, 2009, the Company’s board of directors approved the Apollo Commercial Real Estate Finance, Inc., 2009 Equity Incentive Plan (the “LTIP”). The LTIP provides for grants of restricted common stock, restricted stock units ("RSUs") and other equity-based awards up to an aggregate of 7.5% of the issued and outstanding shares of the Company’s
common stock (on a fully diluted basis). The LTIP is administered by the compensation committee of the Company’s board of directors (the “Compensation Committee”) and all grants under the LTIP must be approved by the Compensation Committee.
The Company recognized stock-based compensation expense of $362 and $788 for the three and six months ended June 30, 2014, respectively, related to restricted stock and RSU vesting. The Company recognized stock-based compensation expense of $428 and $1,311 for the three and six months ended June 30, 2013, respectively, related to restricted stock and RSU vesting. The following table summarizes the grants, exchanges and forfeitures of restricted common stock and RSUs during the six months ended June 30, 2014:
|
| | | | | | | | | | | | | | |
| Type | Date | | Restricted Stock | | RSUs | | Estimate Fair Value on Grant Date | | Initial Vesting | | Final Vesting |
Outstanding at December 31, 2013 | | 208,416 |
| | 503,750 |
| | | | | | |
| Canceled upon delivery | January 2014 | | — |
| | (288,750 | ) | | n/a | | n/a | | n/a |
| Grant | April 2014 | | 13,931 |
| | — |
| | $235 | | July 2014 | | April 2017 |
| Canceled upon delivery | April 2014 | | — |
| | (5,000 | ) | | n/a | | n/a | | n/a |
| Grant | June 2014 | | — |
| | 10,254 |
| | $169 | | December 2014 | | December 2016 |
Outstanding at June 30, 2014 | | 222,347 |
| | 220,254 |
| | | | | | |
Below is a summary of expected restricted common stock and RSU vesting dates as of June 30, 2014.
|
| | | | | | | | |
Vesting Date | Shares Vesting | | RSU Vesting | | Total Awards |
July 2014 | 3,317 |
| | — |
| | 3,317 |
|
July 2014 | 500 |
| | — |
| | 500 |
|
October 2014 | 3,313 |
| | — |
| | 3,313 |
|
December 2014 | 6,668 |
| | 66,750 |
| | 73,418 |
|
January 2015 | 3,320 |
| | — |
| | 3,320 |
|
March 2015 | — |
| | 6,667 |
| | 6,667 |
|
April 2015 | 3,321 |
| | — |
| | 3,321 |
|
July 2015 | 2,522 |
| | — |
| | 2,522 |
|
July 2015 | 500 |
| | — |
| | 500 |
|
October 2015 | 2,522 |
| | — |
| | 2,522 |
|
December 2015 | 6,668 |
| | 66,759 |
| | 73,427 |
|
January 2016 | 2,521 |
| | — |
| | 2,521 |
|
April 2016 | 2,522 |
| | — |
| | 2,522 |
|
July 2016 | 1,578 |
| | — |
| | 1,578 |
|
October 2016 | 1,577 |
| | — |
| | 1,577 |
|
December 2016 | — |
| | 3,418 |
| | 3,418 |
|
January 2017 | 1,161 |
| | — |
| | 1,161 |
|
April 2017 | 1,164 |
| | — |
| | 1,164 |
|
| 43,174 |
| | 143,594 |
| | 186,768 |
|
At June 30, 2014, the Company had unrecognized compensation expense of approximately $630 and $1,996, respectively, related to the vesting of restricted stock awards and RSUs noted in the table above.
RSU Deliveries
During the three months ended June 30, 2014, the Company delivered 240,277 shares of common stock for 283,750 vested RSUs. The Company allows RSU participants to settle their tax liabilities with a reduction of their share delivery from the originally granted and vested RSUs. The amount, when agreed to by the participant, results in a cash payment to the Manager related to this tax liability and a corresponding adjustment to additional paid in capital on the consolidated statement of changes in stockholders' equity. The adjustment was $876 for six months ended June 30, 2014, and is included as a
component of the capital decrease related to the Company's equity incentive plan in the consolidated statement of changes in stockholders’ equity.
Note 14 – Stockholders’ Equity
Common Stock Offering. During the second quarter of 2014, the Company completed a follow-on public offering of 9,706,000 shares of its common stock, including the partial exercise of the underwriters’ option to purchase additional shares, at a price of $16.35 per share. The aggregate net proceeds from the offering, including proceeds from the sale of the additional shares, were approximately $158,398 after deducting estimated offering expenses payable by the Company.
Dividends. For 2014, the Company declared the following dividends on its common stock:
|
| | | | | |
Declaration Date | Record Date | Payment Date | Amount |
February 26, 2014 | March 31, 2014 | April 15, 2014 | $ | 0.40 |
|
April 29, 2014 | June 30, 2014 | July 15, 2014 | $ | 0.40 |
|
For 2014, the Company declared the following dividends on its 8.625% Series A Cumulative Redeemable Perpetual Preferred Stock (the “Series A Preferred Stock”):
|
| | | | | |
Declaration Date | Record Date | Payment Date | Amount |
March 17, 2014 | March 31, 2014 | April 15, 2014 | $ | 0.5391 |
|
June 9, 2014 | June 30, 2014 | July 15, 2014 | $ | 0.5391 |
|
Note 15 – Commitments and Contingencies
KBC Bank Deutschland AG. In September 2013, the Company, together with other affiliates of Apollo, reached an agreement to make an investment in an entity that has agreed to acquire a minority participation in KBC Bank Deutschland AG
(“KBCD”). The Company committed to invest up to approximately $50,000 (€38,000), representing approximately 21% of the ownership in KBCD. The acquisition is subject to regulatory approval, which is expected to conclude during the second half of 2014. Consequently, there is no assurance that the acquisition will close.
Loan Commitments. As described in Note 5, at June 30, 2014, the Company had $100,100 of unfunded loan commitments.
Note 16 – Fair Value of Financial Instruments
The following table presents the carrying value and estimated fair value of the Company’s financial instruments not carried at fair value on the consolidated balance sheet at June 30, 2014 and December 31, 2013:
|
| | | | | | | | | | | | | | | |
| June 30, 2014 | | December 31, 2013 |
| Carrying Value | | Estimated Fair Value | | Carrying Value | | Estimated Fair Value |
Cash and cash equivalents | $ | 63,335 |
| | $ | 63,335 |
| | $ | 20,096 |
| | $ | 20,096 |
|
Restricted cash | 30,127 |
| | 30,127 |
| | 30,127 |
| | 30,127 |
|
Commercial first mortgage loans | 343,810 |
| | 348,043 |
| | 161,099 |
| | 164,405 |
|
Subordinate loans | 748,227 |
| | 664,661 |
| | 497,484 |
| | 503,267 |
|
Borrowings under repurchase agreements | (446,224 | ) | | (444,975 | ) | | (202,033 | ) | | (202,148 | ) |
Convertible senior notes, net | (139,362 | ) | | (151,218 | ) | | — |
| | — |
|
Participations sold | (89,182 | ) | | (89,974 | ) | | — |
| | — |
|
To determine estimated fair values of the financial instruments listed above, market rates of interest, which include credit assumptions, are used to discount contractual cash flows. The estimated fair values are not necessarily indicative of the amount the Company could realize on disposition of the financial instruments. The use of different market assumptions or estimation methodologies could have a material effect on the estimated fair value amounts. The Company’s commercial first mortgage loans, subordinate loans and repurchase agreements are carried at amortized cost on the condensed consolidated financial statements and are classified as Level III in the fair value hierarchy.
Note 17 – Net Income per Share
GAAP requires use of the two-class method of computing earnings per share for all periods presented for each class of common stock and participating security as if all earnings for the period had been distributed. Under the two-class method, during periods of net income, the net income is first reduced for dividends declared on all classes of securities to arrive at undistributed earnings. During periods of net losses, the net loss is reduced for dividends declared on participating securities only if the security has the right to participate in the earnings of the entity and an objectively determinable contractual obligation to share in net losses of the entity.
The remaining earnings are allocated to common stockholders and participating securities to the extent that each security shares in earnings as if all of the earnings for the period had been distributed. Each total is then divided by the applicable number of shares to arrive at basic earnings per share. For the diluted earnings, the denominator includes all outstanding shares of common stock and all potential shares of common stock assumed issued if they are dilutive. The numerator is adjusted for any changes in income or loss that would result from the assumed conversion of these potential shares of common stock.
The table below presents basic and diluted net (loss) income per share of common stock using the two-class method for the three and six months ended June 30, 2014 and 2013:
|
| | | | | | | | | | | | | | | |
| For the three months ended June 30, | | For the six months ended June 30, |
| 2014 | | 2013 | | 2014 | | 2013 |
Numerator: | | | | | | | |
Net income | $ | 23,958 |
| | $ | 11,789 |
| | $ | 41,539 |
| | $ | 23,721 |
|
Preferred dividends | (1,860 | ) | | (1,860 | ) | | (3,720 | ) | | (3,720 | ) |
Net income available to common stockholders | 22,098 |
| | 9,929 |
| | 37,819 |
| | 20,001 |
|
Dividends declared on common stock | (18,739 | ) | | (14,752 | ) | | (33,590 | ) | | (29,500 | ) |
Dividends on participating securities | (88 | ) | | (200 | ) | | (174 | ) | | (395 | ) |
Net income (loss) attributable to common stockholders | $ | 3,271 |
| | $ | (5,023 | ) | | $ | 4,055 |
| | $ | (9,894 | ) |
Denominator: | | | | | | | |
Basic weighted average shares of common stock outstanding | 42,888,747 |
| | 36,880,410 |
| | 40,021,722 |
| | 33,511,889 |
|
Diluted weighted average shares of common stock outstanding | 43,099,354 |
| | 37,373,885 |
| | 40,236,109 |
| | 33,946,329 |
|
Basic and diluted net income per weighted average share of common stock | | | | | | | |
Distributable Earnings | $ | 0.44 |
| | $ | 0.40 |
| | $ | 0.84 |
| | $ | 0.88 |
|
Undistributed income (loss) | $ | 0.07 |
| | $ | (0.13 | ) | | $ | 0.10 |
| | $ | (0.29 | ) |
Basic and diluted net income per share of common stock | $ | 0.51 |
| | $ | 0.27 |
| | $ | 0.94 |
| | $ | 0.59 |
|
Note 18 – Subsequent Events
Dividends. On July 28, 2014, the Company declared a dividend of $0.40 per share of common stock, which is payable on October 15, 2014 to common stockholders of record on September 30, 2014.
Investment Activity. During July 2014, the Company closed a $20,000 floating-rate mezzanine loan secured by the equity interest in a 280-key hotel in the Chelsea neighborhood of New York City. The mezzanine loan has a two-year initial term and three one-year extension options and an appraised loan-to-value ("LTV") of 61%. The mezzanine loan was underwritten to generate an IRR of approximately 12%.
During July 2014, the Company closed a $34,500 ($30,000 of which was funded at closing) floating-rate, first mortgage loan secured by a newly constructed, Class-A, 63-unit multifamily property located in Brooklyn, New York, which also includes approximately 7,300 square feet of retail space and 31 parking spaces. The first mortgage loan has a two-year initial term with three one-year extension options and an appraised LTV of 70% on a fully funded basis. The Company anticipates financing the loan, and on a levered basis, the loan was underwritten to generate an IRR of approximately 12%.
During the third quarter of 2014, the Company deployed $6,369 of equity to acquire legacy CMBS with an aggregate purchase price of $31,844. The Company financed the CMBS utilizing $25,475 of borrowings under the DB Facility. The CMBS have a weighted average life of 2.1 years and have been underwritten to generate an IRR of 16%.
ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
FORWARD-LOOKING INFORMATION
The Company makes forward-looking statements herein and will make forward-looking statements in future filings with the SEC, press releases or other written or oral communications within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). For these statements, the Company claims the protections of the safe harbor for forward-looking statements contained in such Section. Forward-looking statements are subject to substantial risks and uncertainties, many of which are difficult to predict and are generally beyond the Company’s control. These forward-looking statements include information about possible or assumed future results of the Company’s business, financial condition, liquidity, results of operations, plans and objectives. When the Company uses the words “believe,” “expect,” “anticipate,” “estimate,” “plan,” “continue,” “intend,” “should,” “may” or similar expressions, it intends to identify forward-looking statements. Statements regarding the following subjects, among others, may be forward-looking: market trends in the Company’s industry, interest rates, real estate values, the debt securities markets or the general economy or the demand for commercial real estate loans; the Company’s business and investment strategy; the Company’s operating results; actions and initiatives of the U.S. government and changes to U.S. government policies and the execution and impact of these actions, initiatives and policies; the state of the U.S. economy generally or in specific geographic regions; economic trends and economic recoveries; the Company’s ability to obtain and maintain financing arrangements, including securitizations; the anticipated shortfall of debt financing from traditional lenders; the volume of short-term loan extensions; the demand for new capital to replace maturing loans; expected leverage; general volatility of the securities markets in which the Company participates; changes in the value of the Company’s assets; the scope of the Company’s target assets; interest rate mismatches between the Company’s target assets and any borrowings used to fund such assets; changes in interest rates and the market value of the Company’s target assets; changes in prepayment rates on the Company’s target assets; effects of hedging instruments on the Company’s target assets; rates of default or decreased recovery rates on the Company’s target assets; the degree to which hedging strategies may or may not protect the Company from interest rate volatility; impact of and changes in governmental regulations, tax law and rates, accounting guidance and similar matters; the Company’s ability to maintain its qualification as a REIT for U.S. federal income tax purposes; the Company’s ability to remain excluded from registration under the Investment Company Act of 1940, as amended; the availability of opportunities to acquire commercial mortgage-related, real estate-related and other securities; the availability of qualified personnel; estimates relating to the Company’s ability to make distributions to its stockholders in the future; the Company’s understanding of its competition; and the closing of the Company's investment in KBCD.
The forward-looking statements are based on the Company’s beliefs, assumptions and expectations of its future performance, taking into account all information currently available to it. Forward-looking statements are not predictions of future events. These beliefs, assumptions and expectations can change as a result of many possible events or factors, not all of which are known to the Company. See “Item 1A - Risk Factors” of the Company’s Annual Report on Form 10-K for the year ended December 31, 2013. These and other risks, uncertainties and factors, including those described in the annual, quarterly and current reports that the Company files with the SEC, could cause its actual results to differ materially from those included in any forward-looking statements the Company makes. All forward-looking statements speak only as of the date they are made. New risks and uncertainties arise over time and it is not possible to predict those events or how they may affect us. Except as required by law, the Company is not obligated to, and does not intend to, update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Overview
The Company is a REIT that primarily originates, acquires, invests in and manages performing commercial first mortgage loans, subordinate financings, CMBS and other commercial real estate-related debt investments. These asset classes are referred to as the Company’s target assets.
The Company is externally managed and advised by the Manager, an indirect subsidiary of Apollo Global Management, LLC (together with its subsidiaries, “Apollo”), a leading global alternative investment manager with a contrarian and value oriented investment approach in private equity, credit and real estate with assets under management of approximately $159.3 billion as of March 31, 2014.
The Manager is led by an experienced team of senior real estate professionals who have significant expertise in underwriting and structuring commercial real estate financing transactions. The Company benefits from Apollo’s global infrastructure and operating platform, through which the Company is able to source, evaluate and manage potential investments in the Company’s target assets.
Market Overview
The commercial real estate market has largely recovered from the downturn experienced as part of the correction in the global financial markets which began in mid-2007. Property values in many markets and property types have recovered and the lending market is functioning with both established and new entrants. Based on the current market dynamics, including increasing real estate transaction activity and over $1 trillion of commercial real estate debt scheduled to mature through 2017, there remains a compelling opportunity for the Company to source and originate investments in its target assets at attractive risk adjusted returns. The Company will continue to focus on underlying real estate value, and transactions that benefit from the Company’s ability to execute complex and sophisticated transactions.
During and immediately following the financial crisis, due to the prevalence of lenders granting extensions across the commercial mortgage loan industry, the demand for new capital to refinance maturing commercial mortgage debt was somewhat tempered. This trend has abated to a certain extent in more recent periods as many borrowers have refinanced legacy loans and pursued new acquisitions. While the frequency of extensions and modifications had a meaningful impact on the timing of loan maturities, the Company believes the next phase will involve rising volumes of commercial mortgage lending activity which should allow lenders to capitalize on the impending maturity wall. Additionally, as the European senior lending market continues to expand and strengthen, we expect to see an increase in the number and availability of target opportunities.
With the continued tapering of its bond purchases, the Federal Reserve has demonstrated a desire to slowly reduce the amount of stimulus in the economy. While the Federal Reserve has decreased the pace of its bond purchases, the low interest rate environment is expected to persist, remain attractive to borrowers and is projected to continue to drive significant refinancing activity across all property types during 2014.
After seeing substantial growth in 2012 and 2013, new-issue CMBS volume in the first half of 2014 was approximately $43 billion, equal to approximately 82% of the volume during the same period in the prior year. In 2013, approximately $86 billion of CMBS were issued in the United States, an increase of approximately 78% over 2012 and an increase of 163% over 2011. We believe the volume of originations in the CMBS market is evidence that the lending market for commercial real estate has largely stabilized since the financial crisis.
However, current volumes of CMBS issuance are still moderate relative to the peak of the market, which saw more than $229 billion in CMBS issuance in 2007. We perceive that lenders still appear to be focused on stabilized cash flowing assets with loan-to-value ratios lower than peak. As a result, we expect to continue to see opportunities to originate mezzanine and first mortgage financings in transactions which benefit from the Company’s ability to source, structure and execute complex transactions.
Critical Accounting Policies
A summary of the Company’s accounting policies is set forth in its Annual Report on Form 10-K for the year ended December 31, 2013 under “Item 7 – Management's Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Policies and Use of Estimates.”
Significant Accounting Policies
Foreign Currency. The Company may enter into transactions not denominated in U.S. dollars. Foreign exchange gains and losses arising on such transactions are recorded as a gain or loss in the Company's consolidated statements of operations. Non-U.S. dollar denominated assets and liabilities are translated to U.S. dollars at the exchange rate prevailing at the reporting date and income, expenses, gains, and losses are translated at the prevailing exchange rate on the dates that they were recorded.
Participations Sold. Participations sold represent interests in certain loans that the Company originated and subsequently sold. In certain instances, the Company presents these participations sold as both assets and non-recourse liabilities because these arrangements do not qualify as sales under GAAP. Generally, participations sold are recorded as assets and liabilities in equal amounts on the Company's consolidated balance sheets, and an equivalent amount of interest income and interest expense is recorded on the Company's consolidated statements of operations.
Financial Condition and Results of Operations
(in thousands—except share and per share data)
Investments
The following table sets forth certain information regarding the Company’s investments at June 30, 2014:
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Description | Face Amount | | Amortized Cost | | Weighted Average Yield | | Remaining Weighted Average Life (years) | | Debt | | Cost of Funds | | Remaining Debt Term (years) (1) | | Equity at cost (2) | | Current Weighted Average Underwritten IRR (3) (4) | | Levered Weighted Average Underwritten IRR (3) (4) |
First mortgages | $ | 346,485 |
| | $ | 343,810 |
| | 8.4 | % | | 3.0 |
| | $ | 146,698 |
| | 2.7 | % | | 0.6 |
| | $ | 197,112 |
| | 15.0 | % | | 16.4 | % |
Subordinate loans (5) | 661,668 |
| | 659,045 |
| | 11.9 |
| | 3.5 |
| | — |
| | — |
| | — |
| | 659,045 |
| | 12.8 |
| | 12.8 |
|
CMBS | 343,596 |
| | 339,724 |
| | 6.3 |
| | 2.8 |
| | 299,526 |
| | 3.1 |
| | 3.7 |
| | 70,325 |
| | 15.4 |
| | 15.5 |
|
Total/Weighted Average | $ | 1,351,749 |
| | $ | 1,342,579 |
| | 9.6 | % | | 3.2 |
| | $ | 446,224 |
| | 2.9 | % | | 2.7 |
| | $ | 926,482 |
| | 13.6 | % | | 13.9 | % |
| |
(1) | Assumes extension options are exercised. See “—Liquidity and Capital Resources - Borrowings Under Various Financing Arrangements” below for a discussion of the Company's repurchase agreements. |
| |
(2) | Includes $30,127 of restricted cash related to the UBS Facility. |
| |
(3) | The underwritten IRR for the investments shown in the above table reflect the returns underwritten by the Manager, calculated on a weighted average basis assuming no dispositions, early prepayments or defaults but assuming that extension options are exercised and that the cost of borrowings under the Wells Facility remains constant over the remaining term. With respect to certain loans, the underwritten IRR calculation assumes certain estimates with respect to the timing and magnitude of future fundings for the remaining commitments and associated loan repayments, and assumes no defaults. IRR is the annualized effective compounded return rate that accounts for the time-value of money and represents the rate of return on an investment over a holding period expressed as a percentage of the investment. It is the discount rate that makes the net present value of all cash outflows (the costs of investment) equal to the net present value of cash inflows (returns on investment). It is derived from the negative and positive cash flows resulting from or produced by each transaction (or for a transaction involving more than one investment, cash flows resulting from or produced by each of the investments), whether positive, such as investment returns, or negative, such as transaction expenses or other costs of investment, taking into account the dates on which such cash flows occurred or are expected to occur, and compounding interest accordingly. There can be no assurance that the actual IRRs will equal the underwritten IRRs shown in the table. See “Item 1A-Risk Factors-The Company may not achieve its underwritten internal rate of return on its investments which may lead to future returns that may be significantly lower than anticipated” included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013 for a discussion of some of the factors that could adversely impact the returns received by the Company from the investments shown in the table or elsewhere in this quarterly report over time. |
| |
(4) | The Company’s ability to achieve its underwritten levered weighted average IRR with regard to its portfolio of first mortgage loans is dependent upon the Company borrowing approximately $28,302 under the JPMorgan Facility or any replacement facility. Without such reborrowing, the levered weighted average underwritten IRRs will be as indicated in the current weighted average underwritten IRR column above. |
| |
(5) | Subordinate loans are net of a participation sold during June 2014. The Company presents the participation sold as both assets and non-recourse liabilities because the participation does not qualify as a sale according to GAAP. At June 30, 2014, the Company had one such participation sold with a face amount of $90,000 and a carrying amount of $89,182. |
Investment Activity
Investment activity. During February 2014, the Company provided a $80,000, floating rate first mortgage loan ($25,000 of which was funded at closing) for the development of a 50-unit luxury residential condominium in Montgomery County, Maryland. The Company’s loan is expected to fund the first phase of a two-phase development and has a 30-month term with a 6-month extension option. On a fully funded basis, the Company expects that the first mortgage loan will represent an underwritten loan-to-net sellout of approximately 68% and has been underwritten to generate a 15% IRR. See “—Investments” below for a discussion of IRR.
During April 2014, the Company closed a $210,000 fixed-rate, five-year first mortgage loan secured by a portfolio of 229 single-family and condominium homes located across North and Central America, the Caribbean and England. Simultaneous with closing, the Company syndicated $104,000 of the loan to other funds managed by affiliates of Apollo Global Management, LLC and retained $106,000. The first mortgage loan has an appraised loan-to-value of approximately 49% and was underwritten to generate an IRR of approximately 8.2% on an unlevered basis. The Company anticipates financing the investment and on a levered basis, the investment was underwritten to generate an IRR of approximately 15%.
During April 2014, the Company closed a $53,954 (£32,100) fixed rate, nine-month mezzanine loan in connection with the purchase of an existing commercial building that is expected to be re-developed into a 173,000 salable square foot residential condominium in Central London. The mezzanine loan is part of a $126,060 (£75,000) pre-development loan comprised of a $72,106 (£42,900) first mortgage and the Company's $53,954 (£32,100) mezzanine loan. The Company will
have the option, but not the obligation, to participate in the development financing. The Company’s loan basis represents a 78% appraised loan-to-value and the mezzanine loan has been underwritten to generate an IRR of approximately 12%.
During May 2014, the Company closed a $155,000 floating-rate whole loan secured by the first mortgage and equity interests in an entity that owns a resort hotel in Aruba. The property consists of 442 hotels rooms, 114 timeshare units, two casinos and approximately 131,500 square feet of retail space. During June 2014, the Company syndicated a $90,000 senior participation in the loan and retained a $65,000 junior participation in the loan. The whole loan has a three-year term with two one-year extension options and an appraised LTV of 60%. The junior participation was underwritten to generate an IRR of approximately 14%.
During May 2014, the Company closed a $34,000 floating-rate first mortgage loan for the acquisition of a newly renovated 301-key hotel located in downtown Philadelphia. The first mortgage has a three-year term with two one-year extension options and an underwritten loan-to-cost of 58%. The first mortgage loan was underwritten to generate an IRR of approximately 13% on a levered basis.
During June 2014, the Company closed a $65,100 floating-rate first mortgage loan ($20,000 of which was funded at closing) for the development of a 40-unit luxury residential condominium in downtown Bethesda, Maryland. The Company’s loan has a 30-month term with a six-month extension option. On a fully funded basis, the first mortgage loan has a projected appraised loan-to-net sellout of approximately 67% and has been underwritten to generate an IRR of approximately 14%.
During June 2014, the Company closed a $28,250 fixed-rate mezzanine loan secured by the equity interest in a 795-key full-service hotel and 226,000 square foot office and retail condominium in the Times Square neighborhood of New York City. The mezzanine loan has a remaining six months term and an underwritten LTV of 67%. The mezzanine loan was underwritten to generate an IRR of approximately 8%.
During June 2014, the Company closed a $50,000 floating-rate mezzanine loan secured by the equity interest in a portfolio of 167 wholly owned skilled nursing facilities located across 19 states. The mezzanine loan was issued in connection with the refinancing of the portfolio and paid off the existing $47,000 mezzanine loan acquired in 2013. The new mezzanine loan has a two-year initial term with three one-year extension options and an underwritten LTV of 62%. The mezzanine loan was underwritten to generate an IRR of approximately 12%.
During the second quarter of 2014, the Company deployed $34,713 of equity to acquire legacy CMBS originally rated AAA with an aggregate purchase price of $173,567. The Company financed the CMBS utilizing $138,853 of borrowings under the DB Facility. The CMBS have a weighted average life of 2.8 years and have been underwritten to generate an IRR of 17%.
Repayments. During January 2014, the Company received a $15,000 principal repayment from a subordinate loan secured by a pledge of the equity interests in the owner of a New York City hotel. The Company realized a 14% IRR on this subordinate loan.
During June 2014, the Company received a $47,000 principal repayment from a mezzanine loan secured by a pledge of the equity interests in a portfolio of skilled nursing facilities. The Company realized a 12% IRR on this mezzanine loan.
Net Income Available to Common Stockholders
For the three and six months ended June 30, 2014, respectively, the Company’s net income available to common stockholders was $22,098, or $0.51 per share, and $37,819, or $0.94 per share. For the three and six months ended June 30, 2013, respectively, the Company’s net income available to common stockholders was $9,929, or $0.27 per share, and $20,001, or $0.59 per share.
Net Interest Income
The following table sets forth certain information regarding the Company’s net investment income for the three and six months ended June 30, 2014 and 2013:
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Three months ended June 30, | | Six months ended June 30, |
| 2014 | | 2013 | | Change (amount) | | Change (%) | | 2014 | | 2013 | | Change (amount) | | Change (%) |
Interest income from: | | | | | | | | | | | | | | | |
Securities | $ | 4,366 |
| | $ |
|